Treace Medical Concepts logo

Treace Medical ConceptsNASDAQ: TMCI

Profile

Sector:

Healthcare

Country:

United States

IPO:

23 April 2021

Next earnings report:

05 November 2024

Last dividends:

N/A

Next dividends:

N/A
$326.50 M
-81%vs. 3y high
60%vs. sector
-vs. 3y high
-vs. sector
-88%vs. 3y high
69%vs. sector
-89%vs. 3y high
33%vs. sector

Price

regular market | 1 min ago
$5.25+$0.47(+9.83%)

Dividend

No data over the past 3 years
$44.45 M$43.48 M
$44.45 M-$21.21 M

Analysts recommendations

Institutional Ownership

TMCI Latest News

Shareholders that lost money on Treace Medical Concepts, Inc.(TMCI) should contact Levi & Korsinsky about Securities Fraud Investigation - TMCI
accesswire.com04 November 2024 Sentiment: -

NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc.") (NASDAQ:TMCI) concerning possible violations of federal securities laws. On May 7, 2024 Treace Medical Concepts Inc. announced Q1 2024 financial results that met revenue estimates but lowered its guidance for the full year 2024 blaming it on "competitive pressure in its business.

TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm
prnewswire.com04 November 2024 Sentiment: NEGATIVE

LOS ANGELES , Nov. 4, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ: TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Levi & Korsinsky Reminds Shareholders of an Investigation into Treace Medical Concepts, Inc. (TMCI) Regarding Potential Securities Fraud Allegations
accesswire.com03 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 3, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc.") (NASDAQ:TMCI) concerning possible violations of federal securities laws. On May 7, 2024 Treace Medical Concepts Inc. announced Q1 2024 financial results that met revenue estimates but lowered its guidance for the full year 2024 blaming it on "competitive pressure in its business.

The Schall Law Firm Urges Shareholders To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
accesswire.com03 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

TMCI ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Treace Medical Concepts, Inc.
accesswire.com02 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc.") (NASDAQ:TMCI) concerning possible violations of federal securities laws. On May 7, 2024 Treace Medical Concepts Inc. announced Q1 2024 financial results that met revenue estimates but lowered its guidance for the full year 2024 blaming it on "competitive pressure in its business.

Treace Medical Concepts Inc Is Being Looked Into By The Schall Law Firm For Securities Fraud And Affected Investors Are Encouraged To Reach Out
accesswire.com02 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
businesswire.com31 October 2024 Sentiment: NEGATIVE

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMCI) investors concerning the Company's possible violations of federal securities laws. On May 7, 2024, Treace released its first quarter 2024 financial results and revised its full year 2024 guidance, lowering it by approximately $20 million, citing "increased use of MIS Osteotomy solutions and more competition from knockoffs.

The Law Offices of Frank R. Cruz Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
businesswire.com31 October 2024 Sentiment: NEGATIVE

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMCI) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On May 7, 2024, Treace released its first quarter 2024 financial results and revised its full year 2024 guidance, lowering it by approximately $20 million, citing ".

Levi & Korsinsky Announces an Investigation on Behalf of Treace Medical Concepts, Inc. (TMCI) Shareholders Who May Have Been Affected by Fraud
accesswire.com31 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc.") (NASDAQ:TMCI) concerning possible violations of federal securities laws. On May 7, 2024 Treace Medical Concepts Inc. announced Q1 2024 financial results that met revenue estimates but lowered its guidance for the full year 2024 blaming it on "competitive pressure in its business.

Investors Are Invited To Join The Schall Law Firm's Inquiry Into Treace Medical Concepts Inc For Securities Fraud
accesswire.com30 October 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / October 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

  • 1(current)
  • 2
  • 3

What type of business is Treace Medical Concepts?

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

What sector is Treace Medical Concepts in?

Treace Medical Concepts is in the Healthcare sector

What industry is Treace Medical Concepts in?

Treace Medical Concepts is in the Medical Devices industry

What country is Treace Medical Concepts from?

Treace Medical Concepts is headquartered in United States

When did Treace Medical Concepts go public?

Treace Medical Concepts initial public offering (IPO) was on 23 April 2021

What is Treace Medical Concepts website?

https://www.treace.com

Is Treace Medical Concepts in the S&P 500?

No, Treace Medical Concepts is not included in the S&P 500 index

Is Treace Medical Concepts in the NASDAQ 100?

No, Treace Medical Concepts is not included in the NASDAQ 100 index

Is Treace Medical Concepts in the Dow Jones?

No, Treace Medical Concepts is not included in the Dow Jones index

When was Treace Medical Concepts the previous earnings report?

No data

When does Treace Medical Concepts earnings report?

The next expected earnings date for Treace Medical Concepts is 05 November 2024